These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20848636)

  • 21. Multicentric Castleman's disease in HIV infection.
    Collins LS; Fowler A; Tong CY; de Ruiter A
    Int J STD AIDS; 2006 Jan; 17(1):19-24; quiz 25. PubMed ID: 16409673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Castleman disease: a case with atypical presentation.
    Yaris N; Cakir M; Kalyoncu M; Yildiz K; Okten A
    Pediatr Hematol Oncol; 2004; 21(3):203-8. PubMed ID: 15202159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoimmune pancreatitis in the setting of Castleman disease.
    Maithel SK; Pratt W; Kelleher T; Avigan D; Goldman H; Pfeifer W; Pihan GA; Vollmer CM
    Pancreas; 2007 Nov; 35(4):384-7. PubMed ID: 18090252
    [No Abstract]   [Full Text] [Related]  

  • 24. What Is the best treatment for HIV-associated multicentric Castleman disease?
    Bower M; Dalla Pria A
    Clin Adv Hematol Oncol; 2012 Mar; 10(3):207-9. PubMed ID: 22402432
    [No Abstract]   [Full Text] [Related]  

  • 25. Multicentric angiofollicular lymph node hyperplasia in ulcerative colitis. A case report.
    Browne D; Barton EN; Barrow KO; Williams NP; Hanchard B
    West Indian Med J; 1996 Mar; 45(1):34-6. PubMed ID: 8693737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical outcome of superficial and deep Castleman disease.
    Chen CH; Liu HC; Tung KY; Lee JJ; Liu CL; Liu TP
    ANZ J Surg; 2007 May; 77(5):339-43. PubMed ID: 17497971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low dose interferon-alpha therapy for HIV-associated multicentric Castleman's disease.
    Nord JA; Karter D
    Int J STD AIDS; 2003 Jan; 14(1):61-2. PubMed ID: 12590797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clear cell meningioma causing Castleman syndrome in a child.
    Sato T; Sugiyama T; Kawataki T; Sato E; Horikoshi T; Sugita K; Kinouchi H
    J Neurosurg Pediatr; 2010 Jun; 5(6):622-5. PubMed ID: 20515337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Castleman disease in children: a new case].
    Moruno Tirado AA; León Leal JA; Navarro González J; Dabrio Achabal F; Martínez Caro A; Borderas Naranjo F
    An Esp Pediatr; 1988 Apr; 28(4):377-8. PubMed ID: 3400951
    [No Abstract]   [Full Text] [Related]  

  • 30. Mixed variant multicentric Castleman disease treated with rituximab: case report.
    Mian H; Leber B
    J Pediatr Hematol Oncol; 2010 Nov; 32(8):622. PubMed ID: 20921905
    [No Abstract]   [Full Text] [Related]  

  • 31. Multicentric Castleman disease, Kaposi sarcoma, hemophagocytic syndrome, and a novel HHV8-lymphoproliferative disorder.
    Yates JA; Zakai NA; Griffith RC; Wing EJ; Schiffman FJ
    AIDS Read; 2007 Dec; 17(12):596-8, 601. PubMed ID: 18178978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cervical unicentric Castleman disease presenting as a neck mass: case report and review of the literature.
    Liang J; Newman JG; Frank DM; Chalian AA
    Ear Nose Throat J; 2009 May; 88(5):E8. PubMed ID: 19444782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crohn's disease and idiopathic thrombocytopenic purpura in a patient with ectodermal dysplasia and immunodeficiency.
    Motamed F; Zandieh F; Sedighi M
    Iran J Allergy Asthma Immunol; 2006 Sep; 5(3):143-5. PubMed ID: 17237567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Castleman disease: an update on classification and the spectrum of associated lesions.
    Cronin DM; Warnke RA
    Adv Anat Pathol; 2009 Jul; 16(4):236-46. PubMed ID: 19546611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Follicular dendritic cells in multicentric Castleman disease present human herpes virus type 8 (HHV8)-latent nuclear antigen 1 (LANA1) in a proportion of cases and is associated with an enhanced T-cell response.
    El-Daly H; Bower M; Naresh KN
    Eur J Haematol; 2010 Feb; 84(2):133-6. PubMed ID: 19799625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human herpesvirus 8-positive Castleman disease in human immunodeficiency virus-infected patients: the impact of highly active antiretroviral therapy.
    Aaron L; Lidove O; Yousry C; Roudiere L; Dupont B; Viard JP
    Clin Infect Dis; 2002 Oct; 35(7):880-2. PubMed ID: 12228826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful treatment of human immunodeficiency virus-related Castleman's disease with interferon-alpha.
    Kumari P; Schechter GP; Saini N; Benator DA
    Clin Infect Dis; 2000 Aug; 31(2):602-4. PubMed ID: 10987728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of bortezomib on pro-inflammatory cytokine levels and transfusion dependency in a patient with multicentric Castleman disease.
    Hess G; Wagner V; Kreft A; Heussel CP; Huber C
    Br J Haematol; 2006 Sep; 134(5):544-5. PubMed ID: 16856889
    [No Abstract]   [Full Text] [Related]  

  • 39. Multicentric angiofollicular lymph node hyperplasia in children: a clinicopathologic study of eight patients.
    Smir BN; Greiner TC; Weisenburger DD
    Mod Pathol; 1996 Dec; 9(12):1135-42. PubMed ID: 8972472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rituximab failure in fulminant multicentric HIV/human herpesvirus 8-associated Castleman's disease with multiorgan failure: report of two cases.
    Buchler T; Dubash S; Lee V; Chilton D; Cartledge J; Isaacson P; Tedder RS; Lee SM
    AIDS; 2008 Aug; 22(13):1685-7. PubMed ID: 18670234
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.